385 filings
Page 12 of 20
8-K
ydt7g
9 May 11
Adventrx Reports First Quarter 2011 Financial Results
12:00am
8-K
72lrz9vikd aej
11 Apr 11
Adventrx Completes Acquisition of Synthrx
12:00am
8-K
u2ufsmyqk72byamw
22 Mar 11
Departure of Directors or Certain Officers
12:00am
8-K
bmcm6t1hl2y5j
10 Mar 11
Results of Operations and Financial Condition
12:00am
8-K
wc4x7
15 Feb 11
Adventrx Pharmaceuticals Provides Update on ANX-514
12:00am
8-K
gu4jpij
14 Feb 11
Entry into a Material Definitive Agreement
12:00am
8-K
my4mvp
19 Jan 11
Adventrx Pharmaceuticals Receives Pdufa Date for Exelbineâ„¢ Nda
12:00am
8-K
0o1zl nf6v
7 Jan 11
Adventrx Pharmaceuticals Announces Capital Raise of $22.5 Million
12:00am
8-K
li72qurfranqbhsj
7 Jan 11
Other Events
12:00am
8-K
42rhgq
6 Jan 11
Other Events
12:00am
8-K
7ckivs
8 Nov 10
Adventrx Reports Third Quarter Financial Results
12:00am
8-K
q5c88j4 h19o
3 Nov 10
Other Events
12:00am
8-K
ha6mi4 9y6uy
6 Oct 10
Other Events
12:00am
8-K
rdisoy9afa37jy
14 Sep 10
Adventrx Announces 12-MONTH Stability Data Results for ANX-530
12:00am
8-K
5o7xe7zh bjpnvbzp
6 Aug 10
Adventrx Reports Second Quarter Financial Results
12:00am
8-K
9179aoo0ecs38
2 Jul 10
Submission of Matters to a Vote of Security Holders
12:00am
8-K
87ty8u3b 656fe4
30 Jun 10
Adventrx Announces 9-MONTH Stability Data Results for ANX-530
12:00am
8-K
bnnmg lu0cguiz95u
3 May 10
Adventrx Announces 6-MONTH Stability Data Results for ANX-530
12:00am
8-K
uqzh27rb4j
3 May 10
Adventrx Pharmaceuticals Announces Financing
12:00am
8-K
e3grhvywbv
30 Apr 10
Adventrx Reports First Quarter Financial Results
12:00am